Industry Background:
Preventive healthcare is measures taken for disease prevention, before going for treatment. Just as health encloses a variety of physical and mental states, so do disease and disability, which are affected by environmental factors, genetic predisposition, disease agents, and lifestyle choices. Preventive healthcare is important as the prevalence of chronic diseases and deaths from these diseases is rising. With a constant rise in the number of people, especially young children, affected by chronic ailments, the preventive healthcare industry has gained a lot of momentum across the globe. Preventive healthcare is usually of three types – primary prevention, secondary prevention, and tertiary prevention. The Healthcare industry is undergoing a major transformation. One the reason that both consumers and service providers have started treating healthcare more seriously and are working towards innovation to develop standards of living, from a health perspective.
According to AMA Research, the market for Preventive Healthcare Technologies And Services is expected to register a CAGR of 12.9% during the forecast period to 2027. This growth is primarily driven by Growing Demand for Accurate Screening Methods
.
Attributes | Details |
---|
Study Period | 2017-2027 |
Base Year | 2021 |
Forecast Period | 2022-2027 |
Volume Unit | N |
Value Unit | USD (Million) |
Key Companies in Study | Merck & Co. (United States), Lifecom Inc. (United States), Quest Diagnostics, Inc. (United States), 3M (United States), GlaxoSmithKline plc. (United Kingdom), Dilon Technologies, Inc. (United States), Medtronic (Ireland), Alere (United States), Healthways, Inc. (United States), Omnicell, Inc. (United States), McKesson Corporation (United States), Pfizer, Inc. (United States), Novo Nordisk (Denmark), Eli Lilly (United States), Quanterix (United States) and Aetna Inc. (United States) |
Customization Scope | Avail customization with purchase of this report. Add or modify country, region & or narrow down segments in the final scope subject to feasibility |
The Health Care Facilities sector in the Asia Pacific region has been increasing at a sustainable rate and further growth is expected to be witnessed over the forecast period, owing to the robust investments and expansion in production facilities in the region. Major Players, such as Merck & Co. (United States), Lifecom Inc. (United States), Quest Diagnostics, Inc. (United States), 3M (United States), GlaxoSmithKline plc. (United Kingdom), Dilon Technologies, Inc. (United States), Medtronic (Ireland), Alere (United States), Healthways, Inc. (United States), Omnicell, Inc. (United States), McKesson Corporation (United States), Pfizer, Inc. (United States), Novo Nordisk (Denmark), Eli Lilly (United States), Quanterix (United States) and Aetna Inc. (United States) etc have either set up their manufacturing facilities or are planning to start new provision in the dominated region in the upcoming years.
The companies are exploring the market by adopting mergers & acquisitions, expansions, investments, new service launches and collaborations as their preferred strategies. The players are exploring new geographies through expansions and acquisitions to avail a competitive advantage through combined synergies.
Market Drivers
- Growing Demand for Accurate Screening Methods
- Increasing Spending on Preventive Healthcare among Consumers
Market Trend
- Adoption of Technology and IoT in Healthcare
- Increased Focus on Preventive Care and Holistic Wellness
Restraints
- With limited awareness of emerging economies, they are expensive to install
Opportunities
Increasing Government Initiatives and Growing Economies and Are Expected To Drive the Growth of the Asia Pacific Region
Challenges
One of the Challenge of Preventive Services is, to Use it in a Larger Context, Training to Clinicians is needed and Changes in Clinic Procedures are Necessary to Fully Implement the Preventive Services
AMA Research follows a focused and realistic research framework that provides the ability to study the crucial market dynamics in several regions across the world. Moreover, an in-depth assessment is mostly conducted by our analysts on geographical regions to provide clients and businesses the opportunity to dominate in niche markets and expand in emerging markets across the globe. This market research study also showcases the spontaneously changing Players landscape impacting the growth of the market. Furthermore, our market researchers extensively analyze the products and services offered by multiple players competing to increase their market share and presence.
Customization in the Report
AMA Research features not only specific market forecasts but also includes significant value-added commentary on:
- Market Trends
- Technological Trends and Innovations
- Market Maturity Indicators
- Growth Drivers and Constraints
- New Entrants into the Market & Entry/Exit Barriers
- To Seize Powerful Market Opportunities
- Identify Key Business Segments, Market Proposition & Gap Analysis
Against this Challenging Backdrop, Preventive Healthcare Technologies And Services Study Sheds Light on
The Preventive Healthcare Technologies And Services Market status quo and key characteristics. To end this, Analysts at AMA organize and took surveys of the Preventive Healthcare Technologies And Services industry Players. The resultant snapshot serves as a basis for understanding why and how the industry can be expected to change.
Where Preventive Healthcare Technologies And Services industry is heading and what are the top priorities. Insights are drawn from financial analysis, the survey, and interviews with key executives and industry experts.
How every company in this diverse set of Players can best navigate the emerging competition landscape and follow a strategy that helps them position to hold the value they currently claim or capture the new addressable opportunity.